Covalab SAS - Company Review
SummaryCovalab SAS - Company Review
Summary
Covalab SAS (Covalab) is a developer of polyclonal and monoclonal antibodies. The company’s products include primary antibodies, secondary antibodies, isotype controls, loading controls, tags, antibody packs, peptides, proteins, reagents, kits and chemical compounds. It offers primary antibodies such as nucleolin acK88 antibody, consortin antibody, fumonisin antibody, POLR2M antibody, thymosin beta-4 antibody and AMOT antibody. Covalab offers services such as custom polyclonal antibody, custom monoclonal antibody, antibody production, antibody purification, antibody labelling, peptide synthesis and additional services. The company’s antibodies is used treat cancer, cardiovascular and neurological diseases, among others. It markets its products through distributors in the US, Hungary, Germany, the UK and Japan. Covalab is headquartered in Villeurbanne, France.
This comprehensive company report of Covalab SAS provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.